Nucleophosmin is required for DNA integrity and p19Arf protein stability

被引:178
作者
Colombo, E
Bonetti, P
Denchi, EL
Martinelli, P
Zamponi, R
Marine, JC
Helin, K
Falini, B
Pelicci, PG
机构
[1] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[2] IFOM Inst, I-20139 Milan, Italy
[3] Flanders Interuniv Inst Biotechnol, Lab Mol Canc Biol, B-9052 Ghent, Belgium
[4] Univ Perugia, Inst Hematol & Internal Med, I-06100 Perugia, Italy
[5] Univ Milan, Dept Med Surg & Dent, I-20122 Milan, Italy
关键词
D O I
10.1128/MCB.25.20.8874-8886.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nucleophosmin (NPM) is a nucleolar phosphoprotein that binds the tumor suppressors p53 and p19(Arf) and is thought to be indispensable for ribogenesis, cell proliferation, and survival after DNA damage. The NPM gene is the most frequent target of genetic alterations in leukemias and lymphomas, though its role in tumorigenesis is unknown. We report here the first characterization of a mouse NPM knockout strain. Lack of NPM expression results in accumulation of DNA damage, activation of p53, widespread apoptosis, and mid-stage embryonic lethality. Fibroblasts explanted from null embryos fail to grow and rapidly acquire a senescent phenotype. Transfer of the NPM mutation into a p53-null background rescued apoptosis in vivo and fibroblast proliferation in vitro. Cells null for both p53 and NPM grow faster than control cells and are more susceptible to transformation by activated oncogenes, such as mutated Ras or overexpressed Myc. In the absence of NPM, Arf protein is excluded from nucleoli and is markedly less stable. Our data demonstrate that NPM regulates DNA integrity and, through Arf, inhibits cell proliferation and are consistent with a putative tumor-suppressive function of NPM.
引用
收藏
页码:8874 / 8886
页数:13
相关论文
共 43 条
[1]   Checking on DNA damage in S phase [J].
Bartek, J ;
Lukas, C ;
Lukas, J .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) :792-804
[2]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[3]   Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].
Bertwistle, D ;
Sugimoto, M ;
Sherr, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996
[4]   MAJOR NUCLEOLAR PROTEINS SHUTTLE BETWEEN NUCLEUS AND CYTOPLASM [J].
BORER, RA ;
LEHNER, CF ;
EPPENBERGER, HM ;
NIGG, EA .
CELL, 1989, 56 (03) :379-390
[5]   A B-cell-specific DNA recombination complex [J].
Borggrefe, T ;
Wabl, M ;
Akhmedov, AT ;
Jessberger, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17025-17035
[6]   Defining the molecular basis of Arf and Hdm2 interactions [J].
Bothner, B ;
Lewis, WS ;
DiGiammarino, EL ;
Weber, JD ;
Bothner, SJ ;
Kriwacki, RW .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 314 (02) :263-277
[7]   ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway [J].
Brady, SN ;
Yu, Y ;
Maggi, LB ;
Weber, JD .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (21) :9327-9338
[8]   CHARACTERIZATION OF THE CDNA-ENCODING HUMAN NUCLEOPHOSMIN AND STUDIES OF ITS ROLE IN NORMAL AND ABNORMAL GROWTH [J].
CHAN, WY ;
LIU, QR ;
BORJIGIN, J ;
BUSCH, H ;
RENNERT, OM ;
TEASE, LA ;
CHAN, PK .
BIOCHEMISTRY, 1989, 28 (03) :1033-1039
[9]   Nucleophosmin regulates the stability and transcriptional activity of p53 [J].
Colombo, E ;
Marine, JC ;
Danovi, D ;
Falini, B ;
Pelicci, PG .
NATURE CELL BIOLOGY, 2002, 4 (07) :529-533
[10]   Detection of normal and chimeric nucleophosmin in human cells [J].
Cordell, JL ;
Pulford, KAF ;
Bigerna, B ;
Roncador, G ;
Banham, A ;
Colombo, E ;
Pelicci, PG ;
Mason, DY ;
Falini, B .
BLOOD, 1999, 93 (02) :632-642